ConferencePoster
 (2017)

Inhibition of CTGF/CCN2 improves ALS skeletal muscle phenotype and delays disease progression

Gonzalez, D.; Rebolledo D.; Court, F; Cerpa W.; van Zundert B.; Brandan E.